Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

What inspires yeast cells to divide?

01.08.2002


Rockefeller researchers discover unexpected trigger

Often in science a novel set of experiments comes along that forces researchers to abandon old models in exchange for new ones that better fit their observations. This is the case in a new Nature report by Rockefeller University researchers, which finds that past models of cellular division in the simple yeast organism were focused on the wrong protein.

Until now, scientists thought that yeast cells began dividing into two separate cells upon the destruction of a "cyclin" protein called Clb5. But the new research shows that a related protein called Clb2 is in fact the real trigger.



"To our surprise, the current model of cyclins and cellular division in yeast does not appear to hold true," says Ralph Wäsch, M.D., a postdoctoral researcher at Rockefeller and first author of the paper. "We found that replicating cells do divide in the presence of Clb5, which means that its destruction cannot be the signal for division. What’s more, we show that replicating cells cannot divide in the presence of Clb2."

In addition to providing fundamental insight into the "cell cycle," the process by which all cells from yeast to human create exact duplicates of themselves, the findings have implications for treating cancer - which is characterized by a cell cycle gone awry.

"Yeast and human cells share many of the same cell cycle mechanisms," says Frederick R. Cross, Ph.D., head of the Laboratory of Yeast Molecular Genetics and principal author of the paper. "Because of this and because they are easier to work with, yeast organisms are ideal models for studying how the cell cycle may normally work in humans, as well as how it might malfunction in cancer."

How cells reproduce

All eukaryotic cells (cells that contain a nucleus) must undergo some form of a cell cycle in order to grow and reproduce. During this process, two crucial events must occur within a cell’s nucleus: replication of the DNA, called S-phase, and separation of the resulting chromosomes into two groups, called mitosis or M-phase. Completing the cell cycle are two periods of rest, which take place just before both S- and M-phase, and are called G1 and G2, respectively.

Only when the cell senses that these events have transpired without error will it exit mitosis and divide into two daughter cells. At this point, the process either begins anew, or a cell enters a state of dormancy, called G0.

How a cell moves from one phase to the next depends on periodic waves of cyclins: low levels prepare DNA for replication, higher levels trigger S-phase and mitosis, and a drastic drop in cyclin number signals the cell to begin dividing. Equally important to this process are the proteins that cyclins bind to and activate, called cyclin-dependent kinases (CDKs). Once activated, CDKs carry out the specific cellular tasks required for growth and division.

Cancer arises when the body fails to properly regulate this process. For example, healthy cells respond to DNA-damaging agents, such as sunlight or cigarette smoke, by halting their cell cycle while the damage is repaired, or by committing a type of cell suicide called apoptosis. But cancerous cells have lost this system of checks and balances, resulting in uncontrolled cell growth, DNA damage and eventually tumors. This breakdown in the cell cycle is caused by genetic mutations that lead to abnormal quantities of cell cycle proteins, such as the cyclins.

Cellular oscillators

The latest findings also suggest a new way of thinking about a yeast cell’s "oscillators." Oscillators are protein complexes that control the ebb and flow of cyclins within a cell’s nucleus, thereby ensuring an orderly progression through the cell cycle. During mitosis, they signal the cell to destroy certain cyclins, which then forces it to exit mitosis and begin division. In both human and yeast cells, there are two oscillators: the Cdc20 oscillator and the Cdh1 oscillator.

Previously, scientists thought that the Cdc20 oscillator controlled chromosome separation as well as mitotic exit via elimination of Clb5, while the Cdh1 oscillator was thought to complete exit from mitosis by destroying Clb2.

But the new Nature report tells a different story. It shows that the Cdc20 oscillator dictates exit from mitosis via elimination of Clb2, not Clb5. "Previous experiments showing the destruction of Clb5 to be the primary trigger for cell division were not flawed," says Wäsch. "Rather, the conclusions drawn from them were incorrect. We can now go back and reinterpret those experiments as meaning only that the elimination of Clb5 can act as a trigger for mitotic exit under experimental conditions. But we now know that the essential trigger is the direct destruction of Clb2 by Cdc20."

The researchers say that the destruction of Clb5 may instead be required for proper chromosome maintenance.

Interestingly, the results also suggest how the two oscillators may have evolved. According to the researchers, the first oscillator appears to control both chromosome separation and mitotic exit, while the second mainly oversees the break between cycles of growth and division, G1. Because G1 provides higher organisms with the ability to create different types of cells, the researchers speculate that this second oscillator may represent a necessary step in the evolution of both yeast and humans.


This research is funded by Deutsche Krebshilfe, a German cancer research foundation, and the National Institutes of Health.

John D. Rockefeller founded Rockefeller University in 1901 as The Rockefeller Institute for Medical Research. Rockefeller scientists have made significant achievements, including the discovery that DNA is the carrier of genetic information. The University has ties to 21 Nobel laureates, six of which are on campus. Rockefeller University scientists have received this award for two consecutive years: neurobiologist Paul Greengard, Ph.D., in 2000 and cell biologist Günter Blobel, M.D., Ph.D., in 1999, both in Physiology or Medicine. At present, 33 faculty are elected members of the U.S. National Academy of Sciences. Celebrating its Centennial anniversary in 2001, Rockefeller - the nation’s first biomedical research center - continues to lead the field in both scientific inquiry and the development of tomorrow’s scientists.


Whitney Clavin | ErekAlert!

More articles from Life Sciences:

nachricht Repairing damaged hearts with self-healing heart cells
22.08.2017 | National University Health System

nachricht Biochemical 'fingerprints' reveal diabetes progression
22.08.2017 | Umea University

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Fizzy soda water could be key to clean manufacture of flat wonder material: Graphene

Whether you call it effervescent, fizzy, or sparkling, carbonated water is making a comeback as a beverage. Aside from quenching thirst, researchers at the University of Illinois at Urbana-Champaign have discovered a new use for these "bubbly" concoctions that will have major impact on the manufacturer of the world's thinnest, flattest, and one most useful materials -- graphene.

As graphene's popularity grows as an advanced "wonder" material, the speed and quality at which it can be manufactured will be paramount. With that in mind,...

Im Focus: Exotic quantum states made from light: Physicists create optical “wells” for a super-photon

Physicists at the University of Bonn have managed to create optical hollows and more complex patterns into which the light of a Bose-Einstein condensate flows. The creation of such highly low-loss structures for light is a prerequisite for complex light circuits, such as for quantum information processing for a new generation of computers. The researchers are now presenting their results in the journal Nature Photonics.

Light particles (photons) occur as tiny, indivisible portions. Many thousands of these light portions can be merged to form a single super-photon if they are...

Im Focus: Circular RNA linked to brain function

For the first time, scientists have shown that circular RNA is linked to brain function. When a RNA molecule called Cdr1as was deleted from the genome of mice, the animals had problems filtering out unnecessary information – like patients suffering from neuropsychiatric disorders.

While hundreds of circular RNAs (circRNAs) are abundant in mammalian brains, one big question has remained unanswered: What are they actually good for? In the...

Im Focus: RAVAN CubeSat measures Earth's outgoing energy

An experimental small satellite has successfully collected and delivered data on a key measurement for predicting changes in Earth's climate.

The Radiometer Assessment using Vertically Aligned Nanotubes (RAVAN) CubeSat was launched into low-Earth orbit on Nov. 11, 2016, in order to test new...

Im Focus: Scientists shine new light on the “other high temperature superconductor”

A study led by scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg presents evidence of the coexistence of superconductivity and “charge-density-waves” in compounds of the poorly-studied family of bismuthates. This observation opens up new perspectives for a deeper understanding of the phenomenon of high-temperature superconductivity, a topic which is at the core of condensed matter research since more than 30 years. The paper by Nicoletti et al has been published in the PNAS.

Since the beginning of the 20th century, superconductivity had been observed in some metals at temperatures only a few degrees above the absolute zero (minus...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Call for Papers – ICNFT 2018, 5th International Conference on New Forming Technology

16.08.2017 | Event News

Sustainability is the business model of tomorrow

04.08.2017 | Event News

Clash of Realities 2017: Registration now open. International Conference at TH Köln

26.07.2017 | Event News

 
Latest News

Cholesterol-lowering drugs may fight infectious disease

22.08.2017 | Health and Medicine

Meter-sized single-crystal graphene growth becomes possible

22.08.2017 | Materials Sciences

Repairing damaged hearts with self-healing heart cells

22.08.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>